Clinical Trials Directory

Trials / Terminated

TerminatedNCT02393573

Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism

Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism In Patients Undergoing Major Lung or Abdominal Surgery

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Major surgery results in a stress- induced catabolic response, marked by post-operative insulin resistance, hyperglycemia and loss of body protein, which is associated with increased morbidity, mortality and adverse outcomes. There has been a great deal of research on different approaches to optimize post-operative insulin sensitivity including hormonal and nutritional interventions, minimally invasive surgical techniques and epidural anesthesia. However, the correlation between insulin resistance and body protein loss is not well understood. Metformin is the most widely used insulin sensitizing and blood glucose-lowering drug in treatment of type 2 diabetic patients. This study will: 1) estimate the correlation between insulin resistance and body protein loss in pre-diabetic lung/colorectal resection patients; 2) investigate whether the post-operative metabolic state can be improved by the pre-operative administration of metformin; and assess the impact of metformin on surgical complications and hospital length of stay. The results of this study will provide insight into the relationship between insulin resistance and post-operative adverse events and potentially suggest a novel approach to improve outcomes using Metformin, a drug already in wide clinical use.

Conditions

Interventions

TypeNameDescription
DRUGMetforminPatients will take metformin for two weeks before Surgery and 2 days after the surgery
DRUGPlaceboPatients will take Placebo pills for two weeks before Surgery and 2 days after the surgery

Timeline

Start date
2015-11-01
Primary completion
2018-03-01
Completion
2018-03-01
First posted
2015-03-19
Last updated
2018-03-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02393573. Inclusion in this directory is not an endorsement.